SCHEMBL1508

SCHEMBL1508

CC(=O)C=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.55
TDP1 Q9NUW8 2/20 0.43
GLA P06280 1/20 0.43
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA5A P35218 1/20 0.41
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
USP2 O75604 1/20 0.39
AKR1C3 P42330 1/20 0.39
ESR1 P03372 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
ALDH1A1 P00352 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
KMT2A Q03164 3/20 0.37
POLB P06746 2/20 0.37
CFTR P13569 1/20 0.37
NAPRT Q6XQN6 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL30721072 0.84 HSP90AA1 (0.53) HSP90AA1TDP1GLACA2CA4
SCHEMBL7522374 0.81 HSP90AA1 (0.59) HSP90AA1TDP1CA2CA4CA5A
SCHEMBL814 0.81 HSP90AA1 (0.59) HSP90AA1TDP1CA2CA4CA5A
SCHEMBL9476283 0.81 HSP90AA1 (0.50) HSP90AA1CA2CA4CA5AALOX15
Acetaldehyde SCHEMBL31570102 0.78 HSP90AA1 (0.52) HSP90AA1TDP1CA2CA4CA5A
SCHEMBL9374946 0.78 HSP90AA1 (0.47) HSP90AA1CA2CA4CA5AALOX15
SCHEMBL13908046 0.78 HSP90AA1 (0.47) HSP90AA1TDP1GLACA2CA4
SCHEMBL9374953 0.78 HSP90AA1 (0.47) HSP90AA1CA2CA4CA5AALOX15
SCHEMBL23757989 0.77 HSP90AA1 (0.55) HSP90AA1TDP1CA2CA4CA5A
SCHEMBL8317686 0.77 HSP90AA1 (0.46) HSP90AA1TDP1CA2CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1099 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109730-A1 Process For The Preparation Of (3Beta,24S)-25,25,25-Trifluoro-3-Methyl-26,27-Dinorergost-5-ene-3,24-Diol IND CHIMICA SRL (IT) 2026-04-23 US claimed
EP-3681634-A1 USE OF PHOSPHOROUS YLIDES TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS Chevron Phillips Chemical Company LP (US) 2020-07-22 EP claimed
US-10245583-B1 Use of charge-containing molecules linked with covalent bonds to enhance acetylene hydrogenation catalysts CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2019-04-02 US claimed
WO-2019055451-A1 USE OF PHOSPHOROUS YLIDES TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-03-21 WO claimed
US-20190076832-A1 USE OF CHARGE-CONTAINING MOLECULES LINKED WITH COVALENT BONDS TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2019-03-14 US claimed
CN-101153040-A Method for synthesizing polyhydroxy pyrroline acridine alkaloid CHINESE ACAD INST CHEMISTRY (CN) 2008-04-02 CN claimed
JP-1157948-A None JP disclosed
JP-5070394-A None JP disclosed
US-20260116838-A1 NEOCARZILIN DERIVATIVES AS ANTIMETASTATIC AGENTS PURDUE RESEARCH FOUNDATION (US) 2026-04-30 US disclosed
US-20260109730-A1 Process For The Preparation Of (3Beta,24S)-25,25,25-Trifluoro-3-Methyl-26,27-Dinorergost-5-ene-3,24-Diol IND CHIMICA SRL (IT) 2026-04-23 US disclosed
EP-4727923-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA UNIV GEORGIA (US) 2026-04-09 US disclosed
EP-4159727-B1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN MORPHIC THERAPEUTIC INC (US) 2026-04-08 EP disclosed
US-4243683-A INSECTICIDES, MITICIDES MAY & BAKER LIMITED (GB) 1981-01-06 US disclosed
US-4198425-A ANTILIPEMIC AGENTS SANKYO COMPANY LIMITED (JP) 1980-04-15 US disclosed
US-4110534-A PROCESS FOR THE PREPARATION OF 3-VINYL AND SUBSTITUTED VINYL CEPHALOSPORINS GLAXO LABORATORIES LIMITED (GB) 1978-08-29 US disclosed
US-4107431-A ANTIBIOTICS GLAXO LABORATORIES LIMITED (GB) 1978-08-15 US disclosed
US-4065620-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1977-12-27 US disclosed
US-3957836-A QUINONE DERIVATIVES TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-05-18 US disclosed
US-3954811-A PROSTAGLANDIN INTERMEDIATES SUMITOMO CHEMICAL CO., LTD. (JA) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190076832-A1 USE OF CHARGE-CONTAINING MOLECULES LINKED WITH COVALENT BONDS TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS YWHAZ, SLC6A12, CHRNE HSP90AA1 3289/4885TDP1 3567/4885GLA 389/4885
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA CD47, SLC11A2, G6PD HSP90AA1 2888/4885TDP1 4043/4885GLA 4412/4885
US-20260109730-A1 Process For The Preparation Of (3Beta,24S)-25,25,25-Trifluoro-3-Methyl-26,27-Dinorergost-5-ene-3,24-Diol HSD17B7, CYP11B1, CYP11B2 HSP90AA1 1264/4885TDP1 3114/4885GLA 1698/4885
US-10245583-B1 Use of charge-containing molecules linked with covalent bonds to enhance acetylene hydrogenation catalysts YWHAZ, SLC6A12, CHRNE HSP90AA1 3289/4885TDP1 3567/4885GLA 389/4885
US-20260116838-A1 NEOCARZILIN DERIVATIVES AS ANTIMETASTATIC AGENTS SLC75A1, SLC18A3, SLC8A1 HSP90AA1 1215/4885TDP1 1342/4885GLA 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.